Drug: ETOPOSIDE. Injury: Disease progression Quarter: 2016Q3
Total Records: 51 Number of Pages: 3
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 107501853 | ETOPOSIDE. | Disease progression | BRISTOL MYERS SQUIBB | 41.00 YR | M | 73 KG | 20160830 | UG |
| 124743952 | ETOPOSIDE. | Disease progression | ROCHE | 41.00 YR | F | 0 | 20160708 | DK |
| 125244781 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160704 | US | |
| 125258141 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160705 | JP | |
| 125273891 | ETOPOSIDE. | Disease progression | PFIZER | 35.00 YR | M | 160 KG | 20160705 | US |
| 125273951 | ETOPOSIDE. | Disease progression | PFIZER | 5.00 YR | M | 0 | 20160705 | US |
| 125352511 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160707 | JP | |
| 125370571 | ETOPOSIDE. | Disease progression | PFIZER | 53.00 YR | M | 0 | 20160707 | US |
| 125387541 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160708 | US | |
| 125387641 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160708 | US | |
| 125400321 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160708 | BE | |
| 125403281 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160708 | BE | |
| 125424971 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | US | |
| 125425011 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | GB | |
| 125425021 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | GB | |
| 125425041 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | GB | |
| 125425101 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | US | |
| 125425111 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | US | |
| 125425221 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | JP | |
| 125425291 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | JP |
Total Records: 51 Number of Pages: 3